Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology

Identifieur interne : 003D03 ( Main/Merge ); précédent : 003D02; suivant : 003D04

Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology

Auteurs : Christoph Sarrazin [Allemagne] ; Günter Herrmann [Allemagne] ; W. Kurt Roth [Allemagne] ; Jung-Hun Lee [Allemagne] ; Sylvia Marx [Allemagne] ; Stefan Zeuzem [Allemagne]

Source :

RBID : ISTEX:CD15030607CEF15F5B3C21E3E8078FAE6BA5CFF7

English descriptors

Abstract

Abstract: Background/Aims: Hepatitis G virus (HGV) and hepatitis GB virus-C (GBV-C) are recently identified non-A-E hepatitis-associated viruses. The prevalence of HGV/GBV-C in the general population is high (1.0–1.7%), but data on the clinical and histological manifestations of the new viruses are sparse. In the present study we investigated the prevalence and clinical and histological manifestation of HGV/GBV-C infections in patients with elevated aminotransferase levels of unknown etiology. Methods: In 52 of 630 consecutive patients referred for evaluation of elevated aminotransferases the underlying liver disease remained unknown. Serum samples of these 52 patients with elevated aminotransferase levels of unknown etiology were tested for HGV/GBV-C RNA by reverse transcription-polymerase chain reaction (RT-PCR) using primers deduced from nonstructural regions. Cloned PCR products were sequenced and compared by phylogenetic analysis. Results: HGV/GBV-C RNA was consistently detected in 7 of the 52 patients (13%). Sequence and phylogenetic analysis revealed the presence of only one sub-type, with nucleotide sequence homologies between 86 and 91%. All seven patients had persistent viremia for at least 9 months. In six patients liver function test results normalized, and alanine aminotransferase levels remained persistently elevated in only one patient. Four HGV/GBV-C positive and ten HGV/GBV-C negative patients consented to a liver biopsy, which revealed similar results with minimal to mild chronic hepatitis and mild portal fibrosis. Conclusions: The prevalence of HGV/GBV-C infections in patients with elevated aminotransferase of unknown etiology is low. Since clinical, biochemical and histomorphologic features of patients with elevated aminotransferases of unknown etiology with and without HGV/GBV-C infection are indistinguishable, the role of HGV/GBV-C in the pathogenesis of chronic liver disease appears insignificant.

Url:
DOI: 10.1016/S0168-8278(97)80172-9

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:CD15030607CEF15F5B3C21E3E8078FAE6BA5CFF7

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology</title>
<author>
<name sortKey="Sarrazin, Christoph" sort="Sarrazin, Christoph" uniqKey="Sarrazin C" first="Christoph" last="Sarrazin">Christoph Sarrazin</name>
</author>
<author>
<name sortKey="Herrmann, Gunter" sort="Herrmann, Gunter" uniqKey="Herrmann G" first="Günter" last="Herrmann">Günter Herrmann</name>
</author>
<author>
<name sortKey="Kurt Roth, W" sort="Kurt Roth, W" uniqKey="Kurt Roth W" first="W." last="Kurt Roth">W. Kurt Roth</name>
</author>
<author>
<name sortKey="Lee, Jung Hun" sort="Lee, Jung Hun" uniqKey="Lee J" first="Jung-Hun" last="Lee">Jung-Hun Lee</name>
</author>
<author>
<name sortKey="Marx, Sylvia" sort="Marx, Sylvia" uniqKey="Marx S" first="Sylvia" last="Marx">Sylvia Marx</name>
</author>
<author>
<name sortKey="Zeuzem, Stefan" sort="Zeuzem, Stefan" uniqKey="Zeuzem S" first="Stefan" last="Zeuzem">Stefan Zeuzem</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CD15030607CEF15F5B3C21E3E8078FAE6BA5CFF7</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1016/S0168-8278(97)80172-9</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-GGL5F8DB-6/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001673</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001673</idno>
<idno type="wicri:Area/Istex/Curation">001673</idno>
<idno type="wicri:Area/Istex/Checkpoint">001423</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001423</idno>
<idno type="wicri:doubleKey">0168-8278:1997:Sarrazin C:prevalence:and:clinical</idno>
<idno type="wicri:Area/Main/Merge">003D03</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology</title>
<author>
<name sortKey="Sarrazin, Christoph" sort="Sarrazin, Christoph" uniqKey="Sarrazin C" first="Christoph" last="Sarrazin">Christoph Sarrazin</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medizinische Klinik II, Frankfurt am Main</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Herrmann, Gunter" sort="Herrmann, Gunter" uniqKey="Herrmann G" first="Günter" last="Herrmann">Günter Herrmann</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Senckenbergisches Zentrum der Pathologie, University Hospital, Frankfurt am Main</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kurt Roth, W" sort="Kurt Roth, W" uniqKey="Kurt Roth W" first="W." last="Kurt Roth">W. Kurt Roth</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Georg-Speyer-Haus, Frankfurt an Main</wicri:regionArea>
<wicri:noRegion>Frankfurt an Main</wicri:noRegion>
<wicri:noRegion>Frankfurt an Main</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lee, Jung Hun" sort="Lee, Jung Hun" uniqKey="Lee J" first="Jung-Hun" last="Lee">Jung-Hun Lee</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medizinische Klinik II, Frankfurt am Main</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Marx, Sylvia" sort="Marx, Sylvia" uniqKey="Marx S" first="Sylvia" last="Marx">Sylvia Marx</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Georg-Speyer-Haus, Frankfurt an Main</wicri:regionArea>
<wicri:noRegion>Frankfurt an Main</wicri:noRegion>
<wicri:noRegion>Frankfurt an Main</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zeuzem, Stefan" sort="Zeuzem, Stefan" uniqKey="Zeuzem S" first="Stefan" last="Zeuzem">Stefan Zeuzem</name>
<affiliation></affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medizinische Klinik II, Frankfurt am Main</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Hepatology</title>
<title level="j" type="abbrev">JHEPAT</title>
<idno type="ISSN">0168-8278</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1997">1997</date>
<biblScope unit="volume">27</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="276">276</biblScope>
<biblScope unit="page" to="283">283</biblScope>
</imprint>
<idno type="ISSN">0168-8278</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0168-8278</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Active liver disease</term>
<term>Alanine</term>
<term>Alanine aminotransferase levels</term>
<term>Alanine aminotransferases</term>
<term>Aminotransferase</term>
<term>Aminotransferase levels</term>
<term>Amplification product</term>
<term>Antisense primer</term>
<term>Biochemical characteristics</term>
<term>Blood donors</term>
<term>Blood products</term>
<term>Bootstrap resampling</term>
<term>Chain reaction</term>
<term>Chronic liver disease</term>
<term>Clinical characteristics</term>
<term>Clinical course</term>
<term>Consecutive patients</term>
<term>Consensus sequence</term>
<term>Councilman bodies</term>
<term>Different subtypes</term>
<term>Eosinophilic degeneration</term>
<term>Etiology</term>
<term>Genbank accession number</term>
<term>Genome</term>
<term>Genomic organization</term>
<term>Healthy blood donors</term>
<term>Hepatitis</term>
<term>Hepatitis agent</term>
<term>Hepatitis virus</term>
<term>Hepatocyte pyknosis</term>
<term>Histological</term>
<term>Histological examination</term>
<term>Histological manifestation</term>
<term>Initial presentation</term>
<term>International symposium</term>
<term>Kimura correction</term>
<term>Leary</term>
<term>Liver biopsy</term>
<term>Liver disease</term>
<term>Liver enzymes</term>
<term>Liver function tests</term>
<term>Mallory bodies</term>
<term>Mild portal fibrosis</term>
<term>Negative patients</term>
<term>Nonstructural</term>
<term>Nonstructural region</term>
<term>Nonstructural sequences</term>
<term>Nucleotide</term>
<term>Nucleotide sequences</term>
<term>Optimal conditions</term>
<term>Phylogenetic</term>
<term>Phylogenetic analysis</term>
<term>Polymerase chain reaction</term>
<term>Portal fibrosis</term>
<term>Positive patients</term>
<term>Present study</term>
<term>Primer</term>
<term>Program treecon</term>
<term>Reference sequences</term>
<term>Sense primer</term>
<term>Serological tests</term>
<term>Stefan zeuzem</term>
<term>Tertiary referral center</term>
<term>Tree topology</term>
<term>Unknown elevation</term>
<term>Unknown etiology</term>
<term>Unknown origin</term>
<term>Viral hepatitis</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Background/Aims: Hepatitis G virus (HGV) and hepatitis GB virus-C (GBV-C) are recently identified non-A-E hepatitis-associated viruses. The prevalence of HGV/GBV-C in the general population is high (1.0–1.7%), but data on the clinical and histological manifestations of the new viruses are sparse. In the present study we investigated the prevalence and clinical and histological manifestation of HGV/GBV-C infections in patients with elevated aminotransferase levels of unknown etiology. Methods: In 52 of 630 consecutive patients referred for evaluation of elevated aminotransferases the underlying liver disease remained unknown. Serum samples of these 52 patients with elevated aminotransferase levels of unknown etiology were tested for HGV/GBV-C RNA by reverse transcription-polymerase chain reaction (RT-PCR) using primers deduced from nonstructural regions. Cloned PCR products were sequenced and compared by phylogenetic analysis. Results: HGV/GBV-C RNA was consistently detected in 7 of the 52 patients (13%). Sequence and phylogenetic analysis revealed the presence of only one sub-type, with nucleotide sequence homologies between 86 and 91%. All seven patients had persistent viremia for at least 9 months. In six patients liver function test results normalized, and alanine aminotransferase levels remained persistently elevated in only one patient. Four HGV/GBV-C positive and ten HGV/GBV-C negative patients consented to a liver biopsy, which revealed similar results with minimal to mild chronic hepatitis and mild portal fibrosis. Conclusions: The prevalence of HGV/GBV-C infections in patients with elevated aminotransferase of unknown etiology is low. Since clinical, biochemical and histomorphologic features of patients with elevated aminotransferases of unknown etiology with and without HGV/GBV-C infection are indistinguishable, the role of HGV/GBV-C in the pathogenesis of chronic liver disease appears insignificant.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D03 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003D03 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:CD15030607CEF15F5B3C21E3E8078FAE6BA5CFF7
   |texte=   Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021